Invivoscribe, Inc. Overview
Company Headquarters: California, US
Founded: 1995
Workforce: 200+
Company Working: Invivoscribe, Inc. (Invivoscribe) is into products in the fields of next-generation sequencing, ABI fluorescence detection, gel detection, controls, and reagents. It provides clinical lab services such as NGS cancer panels, MRD NGS tests, targeted genes, clonality NGS tests, and companion diagnostic tests. It offers its products for the treatment and diagnosis of diseases such as mature B-cell lymphoid, mature T-cell lymphoid, myelodysplastic syndromes, acute myeloid leukemia, myeloproliferative neoplasms, and for other hematological diseases.
Strategy
Invivoscribe is focused on improving the quality of healthcare worldwide by providing high quality, reliable, cutting-edge tools for molecular biology, molecular diagnostics, and personalized molecular medicine. The company also focuses on the development of new products.
